Aptose Biosciences

[Not Yet Scheduled]
Aptose Biosciences is a clinical-stage biotechnology company advancing targeted agents to treat hematologic malignancies, including AML, MDS, CLL, and NHL.
Ticker:
APTO
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
CG-806
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Aptose Biosciences